Literature DB >> 16754810

Does aspirin reduce the benefit of an angiotensin-converting enzyme inhibitor? Choosing between the Scylla of observational studies and the Charybdis of subgroup analysis.

Pardeep Jhund, John J V McMurray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16754810     DOI: 10.1161/CIRCULATIONAHA.106.629212

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  2 in total

Review 1.  Medications and Prescribing Patterns as Factors Associated with Hospitalizations from Long-Term Care Facilities: A Systematic Review.

Authors:  Kate N Wang; J Simon Bell; Esa Y H Chen; Julia F M Gilmartin-Thomas; Jenni Ilomäki
Journal:  Drugs Aging       Date:  2018-05       Impact factor: 3.923

2.  Zofenopril: Blood pressure control and cardio-protection.

Authors:  Claudio Borghi; Giuseppe Ambrosio; Philippe Van De Borne; Giuseppe Mancia
Journal:  Cardiol J       Date:  2021-10-08       Impact factor: 2.737

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.